Dougherty & Co Downgrades Dolby Laboratories (DLB) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- S&P 500, Dow set for higher open with focus on Mideast developments
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Don’t expect a grand bargain from the Trump-Xi summit: Yardeni
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Dolby Laboratories Inc. (DLB) Tops Q3 EPS by 17c; Guides FY13 Revs Below
July 25, 2013 4:53 PM EDTDolby Laboratories Inc. (NYSE: DLB) reported Q3 EPS of $0.47, $0.17 better than the analyst estimate of $0.30. Revenue for the quarter came in at $207.1 million versus the consensus estimate of $208.8 million.
Dolby Laboratories Inc. sees Q4 2013 EPS of $0.30-$0.36, versus the consensus of $0.43. Dolby... More
